0001103021-22-000025.txt : 20220131
0001103021-22-000025.hdr.sgml : 20220131
20220131180638
ACCESSION NUMBER: 0001103021-22-000025
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220127
FILED AS OF DATE: 20220131
DATE AS OF CHANGE: 20220131
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Watson W. Mark
CENTRAL INDEX KEY: 0001612372
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31361
FILM NUMBER: 22575908
MAIL ADDRESS:
STREET 1: 324 S. HYDE PARK AVENUE
STREET 2: STE 350
CITY: TAMPA
STATE: FL
ZIP: 33606
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIODELIVERY SCIENCES INTERNATIONAL INC
CENTRAL INDEX KEY: 0001103021
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 352089858
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4131 PARKLAKE AVENUE
STREET 2: SUITE 225
CITY: RALEIGH
STATE: NC
ZIP: 27612
BUSINESS PHONE: 919 582 9050
MAIL ADDRESS:
STREET 1: 4131 PARKLAKE AVENUE
STREET 2: SUITE 225
CITY: RALEIGH
STATE: NC
ZIP: 27612
FORMER COMPANY:
FORMER CONFORMED NAME: MAS ACQUISITION XXIII CORP
DATE OF NAME CHANGE: 20000111
4
1
wf-form4_164367038088743.xml
FORM 4
X0306
4
2022-01-27
0
0001103021
BIODELIVERY SCIENCES INTERNATIONAL INC
BDSI
0001612372
Watson W. Mark
C/O BIODELIVERY SCIENCES INTL, INC.
4131 PARKLAKE AVE. SUITE 225
RALEIGH
NC
27612
1
0
0
0
Common Stock
2022-01-27
4
M
0
7684
0
A
90663
D
Stock Options (right to buy)
3.66
2022-01-27
4
A
0
85760
3.66
A
2032-01-26
Common Stock
85760.0
85760
D
Restricted Stock Units
0.0
2022-01-27
4
A
0
15369
0
A
2023-01-27
Common Stock
15369.0
15369
D
Restricted Stock Units
0.0
2022-01-27
4
M
0
7684
0
D
2023-01-27
Common Stock
7684.0
7685
D
The Restricted Stock Units ("RSUs") were issued to the Reporting Person on January 27, 2022, as compensation for service on the Issuer's board of directors, pursuant to a grant under the Issuer's 2019 Stock Option Incentive Plan ("the Plan"). The award is subject to time-based vesting and vests in equal portions on: (i) January 27, 2022; and (ii) January 27, 2023.
The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on January 27, 2022.
The stock options were issued to the Reporting Person on January 27, 2022, as compensation for service on the Issuer's board of directors, pursuant to a grant under the Plan. The award is subject to time-based vesting and vests in equal portions on: (i) January 27, 2022; and (ii) January 27, 2023.
/s/ William Mark Watson
2022-01-31